Clinical Trial Update: Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the efficacy and safety of adding vildagliptin to insulin therapy in patients with type 2 diabetes mellitus; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (Galvus) (vildagliptin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 4 | Status: COMPLETED | Results posted: 2016-03-01